1-4 of 4
Satoshi Nishikawa
Close
Sort by
Journal Articles

First Preclinical Report of the Efficacy and PD Results of KHK2823, a Non-Fucosylated Fully Human Monoclonal Antibody Against IL-3Rα

Tadakazu Akiyama, PhD, Shin-ichiro Takayanagi, PhD, Yoshimi Maekawa, Kohta Miyawaki, MD, Fumiaki Jinnouchi, MD, Takashi Jiromaru, MD, Takeshi Sugio, MD, Shinya Daitoku, MD, Hirotake Kusumoto, MD, Munetake Shimabe, PhD, Satoshi Nishikawa, Kengo Yamawaki, Kousuke Iijima, Masanori Hiura, Takeshi Takahashi, PhD, Yoshikane Kikushige, MD PhD, Hiromi Iwasaki, MD PhD, Koichi Akashi, MD PhD, Tomonori Tawara, PhD
Journal: Blood
Blood (2015) 126 (23): 1349.
https://doi.org/10.1182/blood.V126.23.1349.1349
Published: 2015
Journal Articles

Thrombopoietin/MPL signaling confers growth and survival capacity to CD41-positive cells in a mouse model of Evi1 leukemia

Satoshi Nishikawa, Shunya Arai, Yosuke Masamoto, Yuki Kagoya, Takashi Toya, Naoko Watanabe-Okochi, Mineo Kurokawa
Journal: Blood
Blood (2014) 124 (24): 3587–3596.
https://doi.org/10.1182/blood-2013-12-546275
Published: 2014
Journal Articles

Inhibition of EZH2 Depletes MLL Fusion Leukemia Stem Cells Through Restoration of p16 Expression

Koki Ueda, Akihide Yoshimi, Masahiro Nakagawa, Satoshi Nishikawa, Victor E Marquez, Keiki Kumano, Mineo Kurokawa, M.D.
Journal: Blood
Blood (2012) 120 (21): 3510.
https://doi.org/10.1182/blood.V120.21.3510.3510
Published: 2012
Journal Articles

CD41 and Mpl Positive Fraction Shows an Efficient Leukemia-Initiating Capacity in Evi1-Induced Leukemia

Satoshi Nishikawa, Shunya Arai, M.D., Naoko Watanabe-Okochi, M.D., Mineo Kurokawa, M.D.
Journal: Blood
Blood (2012) 120 (21): 1295.
https://doi.org/10.1182/blood.V120.21.1295.1295
Published: 2012